Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Psoriasis Area and Severity Index")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

Cost of psoriasis: A study on the morbidity and financial effects of having psoriasis in AustraliaJENNER, Nicole; CAMPBELL, Jan; PLUNKETT, Anne et al.Australasian journal of dermatology. 2002, Vol 43, Num 4, pp 255-261, issn 0004-8380, 7 p.Article

Current severe psoriasis and the Rule of TensFINLAY, A. Y.British journal of dermatology (1951). 2005, Vol 152, Num 5, pp 861-867, issn 0007-0963, 7 p.Article

Unmet needs in the treatment of psoriasisKRAGBALLE, Knud; VAN DE KERKHOF, Peter C. M; GORDON, Kenneth B et al.EJD. European journal of dermatology. 2014, Vol 24, Num 5, pp 523-532, issn 1167-1122, 10 p.Article

Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trialHOLICK, M. F; CHIMEH, F. N; RAY, S et al.British journal of dermatology (1951). 2003, Vol 149, Num 2, pp 370-376, issn 0007-0963, 7 p.Article

A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scoresDE JAGER, M. E. A; VAN DE KERKHOF, P. C. M; DE JONG, E. M. G. J et al.British journal of dermatology (1951). 2010, Vol 163, Num 5, pp 1099-1101, issn 0007-0963, 3 p.Article

Severity of psoriasis and health-related quality of life : the moderating effects of temperamentJANOWSKI, K; STEUDEN, S.British journal of dermatology (1951). 2008, Vol 158, Num 3, pp 633-635, issn 0007-0963, 3 p.Article

A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis : Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global AssessmentBERTH-JONES, J; GROTZINGER, K; RAINVILLE, C et al.British journal of dermatology (1951). 2006, Vol 155, Num 4, pp 707-713, issn 0007-0963, 7 p.Article

Gene expression profiles in psoriasis : analysis of impact of body site location and clinical severityQUEKENBORN-TRINQUET, V; FOGEL, P; GRIFFITHS, C. E. M et al.British journal of dermatology (1951). 2005, Vol 152, Num 3, pp 489-504, issn 0007-0963, 16 p.Article

The Psoriasis Area and Severity Index is the adequate criterion to define severity in Chronic plaque-type PsoriasisSCHMITT, Jochen; WOZEL, Gottfried.Dermatology (Basel). 2005, Vol 210, Num 3, pp 194-199, issn 1018-8665, 6 p.Article

The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasisCHLADEK, Jaroslav; SIMKOVA, Marie; VANECKOVA, Jaroslava et al.European journal of clinical pharmacology. 2008, Vol 64, Num 4, pp 347-355, issn 0031-6970, 9 p.Article

Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasisSOFEN, Howard; SMITH, Stacy; YUHUA WANG et al.Journal of allergy and clinical immunology. 2014, Vol 133, Num 4, pp 1032-1040, issn 0091-6749, 9 p.Article

Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris : A prospective studySCHMITT, Jochen; HEESE, Elisabeth; WOZEL, Gottfried et al.Dermatology (Basel). 2007, Vol 214, Num 1, pp 68-76, issn 1018-8665, 9 p.Article

A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severityVAN DE KERKHOF, P. C. M; WASEL, N; KRAGBALLE, K et al.Dermatology (Basel). 2005, Vol 210, Num 4, pp 294-299, issn 1018-8665, 6 p.Article

Psoriasis and Psoriatic Arthritis Video Project: An Update from the GRAPPA 2011 Annual MeetingCALLIS DUFFIN, Kristina; ARMSTRONG, April W; MEASE, Philip J et al.Journal of rheumatology. 2012, Vol 39, Num 11, pp 2198-2200, issn 0315-162X, 3 p.Conference Paper

Psoriasis and Psoriatic Arthritis Video Project 2010: A Report from the GRAPPA Annual Meeting : Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)CALLIS DUFFIN, Kristina; MEASE, Philip J.Journal of rheumatology. 2011, Vol 38, Num 3, pp 562-563, issn 0315-162X, 2 p.Article

Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapyHASHIMOTO, Takashi; KAWAKAMI, Tamihiro; KARASHIMA, Tadashi et al.Australasian journal of dermatology. 2012, Vol 53, Num 3, pp 202-206, issn 0004-8380, 5 p.Article

Methotrexate vs. ciclosporin in psoriasis : effectiveness, quality of life and safety. A randomized controlled trialFLYTSTRÖM, I; STENBERG, B; SVENSSON, A et al.British journal of dermatology (1951). 2008, Vol 158, Num 1, pp 116-121, issn 0007-0963, 6 p.Article

T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): Mechanisms of actionJULLIEN, D; PRINZ, J. C; LANGLEY, R. G. B et al.Dermatology (Basel). 2004, Vol 208, Num 4, pp 297-306, issn 1018-8665, 10 p.Article

Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaquesMAREPALLY, Srujan; CEDAR HA BOAKYE; PATEL, Apurva R et al.Nanomedicine (London. Print). 2014, Vol 9, Num 14, pp 2157-2174, issn 1743-5889, 18 p.Article

Folic acid supplementation during treatment of psoriasis with methotrexate : a randomized, double-blind, placebo-controlled trialSALIM, A; TAN, E; ILHYSHYN, A et al.British journal of dermatology (1951). 2006, Vol 154, Num 6, pp 1169-1174, issn 0007-0963, 6 p.Article

Biologie agents in psoriasisLEE, Michael R; COOPER, Alan J.Australasian journal of dermatology. 2006, Vol 47, Num 4, pp 217-230, issn 0004-8380, 14 p.Article

Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers -IL-12, IL-18 and IL-23PISKIN, G; TURSEN, U; SYLVA-STEENLAND, R. M. R et al.Experimental dermatology. 2004, Vol 13, Num 12, pp 764-772, issn 0906-6705, 9 p.Article

Leflunomide improves psoriasis in patients with psoriatic arthritis : An in-depth analysis of data from the TOPAS studyNASH, Peter; THACI, Diamant; BEHRENS, Frank et al.Dermatology (Basel). 2006, Vol 212, Num 3, pp 238-249, issn 1018-8665, 12 p.Article

Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque PsoriasisREVICKI, Dennis A; WILLIAN, Mary K; MENTER, Alan et al.Dermatology (Basel). 2008, Vol 216, Num 3, pp 260-270, issn 1018-8665, 11 p.Article

  • Page / 1